Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best biotech stocks to buy according to Wall Street analysts.

Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...

Idorsia’s dual orexin receptor antagonist, the first and only drug of its kind approved in Europe for the treatment of ...

Amid a challenging climate for Vancouver’s life sciences sector, Zymeworks Inc. (Nasdaq:ZYME) stands out as a success story ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best biotech stocks to buy according to Wall Street analysts.

With regulators across Asia-Pacific easing pathways for new therapies, Dimerix is positioning DMX-200 for one of the world’s ...

Seventy-three pharmaceutical, biotechnology and medical device companies from mainland China filed for IPOs in Hong Kong this year, a review by BioWorld found. In the second half of 2025, 43 new ...

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...

Learn more about whether Immunocore Holdings plc or Ultragenyx Pharmaceutical Inc. is a better investment based on AAII's A+ ...

Shares of Regeneron Pharmaceuticals ( REGN 0.56%), a biotech giant, have been southbound over the past two years as the ...